Mona Hussein Abdel-Rahim

Mona Hussein Abdel-Rahim

Auto-generated profile, based on publicly available information

Mona Hussein Abdel-Rahim

Department of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2019 in Acta Oncologica
Verified
Journal Article
Closed access
AZAsmaa M. Zahran
Asmaa M. Zahran
MAMona H. Abdel-Rahim
Mona H. Abdel-Rahim
ARAhmed Refaat
Ahmed Refaat
MSMona Sayed
Mona Sayed
MOMostafa M. Othman
Mostafa M. Othman
Helal HettaHelal Hetta
Helal Hetta
Background and aim: Circulating hematopoietic stem cells (HSCs), circulating endothelial progenitor cells (EPCs) and cancer stem cells (CSCs) contribute to tumor development and progression and can predict patient outcome. The aim of this study was to investigate the frequency of circulating HSCs, EPCs and CSCs in the peripheral blood of patients with hepatocellular carcinoma (HCC) and to explore their potential prognostic significance for HCC patients. Methods: The study included 30 HCC patients and 20 healthy controls. The HSCs and EPCs were enumerated with CD45, CD34, CD133, CD144 markers, while CSCs were enumerated with CD45, CD44, CD133 markers using flow cytometry. Results: The mean percentages of circulating HSCs were significantly lower in HCC patients than the controls (p = .001), whereas the mean percentages of EPCs within the HSCs subpopulation were significantly higher in the HCC patients than the controls (p = .002). The absolute count of CSCs within 100,000 peripheral blood mononuclear cells was 23.5 ± 3.4 in the HCC patients. Also, the mean percentages of circulating HSCs, EPCs and the number of CSCs were significantly increased in patients with multiple hepatic focal lesions than in patients with a single hepatic focal lesion. Both circulating HSCs and EPCs showed significant positive correlation with the level of AFP and with the numbers of CSCs. In the meantime, the numbers of CSCs revealed significant direct correlation with ALT, AST and AFP levels. The one-year overall survival (OS) of the patients was 77.5%. High levels of CSCs, HSCs and EPCs at diagnosis were all associated with worse outcome for the HCC patients. Conclusions: Significant changes in the levels of the circulating HSCs, EPCs and CSCs occur in HCC. These changes help the diagnosis and the prediction of HCC outcome, as higher levels of these cells are associated with worse OS.

1 August 2020 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
OEOmnia El-Badawy
Omnia El-Badawy
AHAmany S. Helmy
Amany S. Helmy
AAAhmed Abbas
Ahmed Abbas
AZAsmaa M. Zahran
Asmaa M. Zahran
NANoha A. Afifi
Noha A. Afifi
MAMona H. Abdel-Rahim
Mona H. Abdel-Rahim

20 January 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AZAsmaa M. Zahran
Asmaa M. Zahran
ARAmal Rayan
Amal Rayan
ZZZeinab Albadry M. Zahran
Zeinab Albadry M. Zahran
WMWael M. Y. Mohamed
Wael M. Y. Mohamed
DMDalia O. Mohamed
Dalia O. Mohamed
OEOmnia El-Badawy
Omnia El-Badawy
Background and aim: Growing evidence highlighted the primary role of the immune system in the disease course of triple-negative breast cancer (TNBC). The study aim was to investigate the expression of PD-1 and CD39 on CD4+and CD8+cells infiltrating tumor tissue compared to their counterparts in peripheral blood and explore its association with tumor characteristics, disease progression, and prognosis in females with TNBC.Patients and methods: The study included 30 TNBC patients and 20 healthy controls. Cancer and normal breast tissue and peripheral blood samples were collected for evaluation of the expression of PD-1 and CD39 on CD4+and CD8+T cells by flow cytometry.Results: A marked reduction in the percentage of CD8+T lymphocytes and a significant increase in the frequencies of CD4+T lymphocytes and CD4+and CD8+T lymphocytes expressing PD1 and CD39 were evident in tumor tissue in comparison with the normal breast tissue. The DFS was inversely related to the cancer tissue PD1+CD8+and CD39+CD8+T lymphocytes. Almost all studied cells were significantly increased in the tumor tissue than in peripheral blood. Positive correlations were detected among peripheral PD1+CD4+T lymphocytes and each of cancer tissue PD1+CD4+, PD1+CD8+and CD39+CD8+T cells, and among peripheral and cancer tissue CD39+CD4+and CD39+CD8+T cells.Conclusions: The CD39 and PD1 inhibitory pathways are synergistically utilized by TNBC cells to evade host immune response causing poor survival. Hence, combinational immunotherapy blocking these pathways might be a promising treatment strategy in this type of cancer.

20 February 2020 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
AZAsmaa M. Zahran
Asmaa M. Zahran
SMSawsan M. Moeen
Sawsan M. Moeen
ATAhmad F. Thabet
Ahmad F. Thabet
ARAmal Rayan
Amal Rayan
MAMona Hussein Abdel-Rahim
Mona Hussein Abdel-Rahim
Helal HettaHelal Hetta
Helal Hetta
This study aimed to analyze the frequency of peripheral Mo-myeloid-derived suppressor cells (Mo-MDSCs) in newly diagnosed CLL patients and to correlate their level with other prognostic factors such as frequency of CD38 cells and ZAP-70 cells and with the clinical response and survival outcomes in these patients. Fifty CLL patients and 20 age-matched healthy controls were included in this study. Flow cytometric detection of ZAP 70, CD38, and Mo-MDSCs was done. Mo-MDSC levels wer significantly higher in CLL patients (27.51 ± 1.70) than healthy controls (16.79 ± 0.66; p < .0001). Higher levels of Mo-MDSCs were detected in advanced Rai clinical staging than Stage I. Mo-MDSCs level was significantly correlated with the frequency of CD38 (r = 0.505; p < .0001) and ZAP-70 cells (r = 0.421; p < .0001). Higher levels of Mo-MDSCs predict poor survival in CLL patients with Mo-MDSCs levels 25% (n = 29; log - Rank test, p < .0001). In conclusion, Mo-MDSCs are correlated with tumor progression and a poor prognosis in CLL.

1 August 2021 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
AZAsmaa M Zahran
Asmaa M Zahran
OEOmnia El-Badawy
Omnia El-Badawy
LKLamiaa M Kamel
Lamiaa M Kamel
ARAmal Rayan
Amal Rayan
KRKhalid Rezk
Khalid Rezk
MAMona H Abdel-Rahim
Mona H Abdel-Rahim
Background and Aim: The present study was conducted to evaluate the number of Tregs in triple negative breast cancer (TNBC), in normal breast parenchyma and in the peripheral blood of these patients and controls, in addition to their correlations with the clinico-pathologic features and the outcomes of TNBC. Methods: Thirty adult treatment-naïve women with non-metastatic TNBC were recruited. In addition, 20 ages matched healthy females participated as a control group. Peripheral blood samples were collected from all participants in tubes containing heparin, fresh tumor tissues were also obtained from all patients undergoing surgery, and 20 normal breast tissue samples were obtained from the same patients’ areas adjacent to the safety margins; all these samples were taken for flow cytometric detection of Tregs. Results: The mean percentages of CD4+CD25+highT cells and Tregs were higher in TNBC peripheral blood than healthy controls and in malignant tissue than normal tissue. Moreover, the frequencies of tumor-infiltrating CD4+T cells and Tregs were exceeding those in the peripheral blood of cancer patients. Only tumor-infiltrating Tregs have shown increasing levels with the increase in the tumor size and were significantly higher in patients with local recurrences than those without recurrence. In addition, Tregs showed significant inverse relation with DFS and direct relation with the level of the peripheral Tregs. Conclusion: The findings of the current study support the possibility that TNBC microenvironment conveys specific characteristics on Tregs distinguishing them from those in normal breast tissue or Tregs in peripheral blood, improving the capabilities of tumor-infiltrating Tregs to enhance tumor growth, local recurrence and reduce the DFS.

1 January 2019 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
AZAsmaa M. Zahran
Asmaa M. Zahran
IMIsmail L. Mohamed
Ismail L. Mohamed
OEOsama El-Asheer
Osama El-Asheer
DTDeiaaeldin M. Tamer
Deiaaeldin M. Tamer
MAMohamed G. M. Abo-Elela
Mohamed G. M. Abo-Elela
KEKhalid I. Elsayh
Khalid I. Elsayh
Background and Aim: Hyperglycemia in type 1 diabetes (T1D) is accompanied by endothelial cell dysfunction which is known to contribute to the pathogenesis of cardiovascular disorders. The aim of the current study was to explore the profile of circulating endothelial progenitor cells (EPCs), circulating endothelial cells (CECs), endothelial and platelet derived micropaticles (EMPs, PMPs) and total microparticles (TMPs), in T1D children in relation to each other and to the metabolic disorders accompanying T1D. Patients and Methods: Thirty T1D patients and 20 age and sex matched healthy volunteers were assessed for HbA1c level and lipid profile. Quantification of CECs, EPCs, TMPs, EMPs and PMPs was done by flow cytometry. Results: The mean levels of EMPs, PMPs, TMPs and CECs were significantly higher in diabetic children compared to controls. Meanwhile, the levels of EPCs were significantly lower in diabetic children compared to controls. Both PMPs and CECs showed the highest significant differences between patients and controls and their levels were directly related to HbA1c, total cholesterol, LDL and triglycerides. A moderate correlation was observed between the frequency of PMPs and CECs. EPCs revealed negative correlations with both LDL and triglycerides. TMPs were only related to LDL, while EMPs were only related to HbA1c. Conclusion: Although there is disturbance in the levels of EMPs, PMPs, TMPs, CECs and EPCs in type 1 diabetic children compared to the controls, only the levels of PMPs and CECs were closely affected by the poor glycemic control and dyslipidemia occurring in T1D; thus may contribute to a higher risk of cardiovascular diseases.